Published in Urol Int on April 15, 2010
C-reactive protein as a biomarker for urological cancers. Nat Rev Urol (2011) 1.21
Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer (2012) 1.06
Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis. Sci Rep (2015) 0.86
A prospective study of the role of inflammation in bladder cancer. Curr Urol (2013) 0.83
Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder Cancer. Dis Markers (2016) 0.79
A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet. PeerJ (2015) 0.77
Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort. PLoS One (2015) 0.75
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy. Prostate Cancer Prostatic Dis (2016) 0.75
Preoperative Glasgow prognostic score as a predictor of primary bladder cancer recurrence. Mol Clin Oncol (2016) 0.75
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol (2010) 4.83
The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol (2013) 4.09
A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer (2011) 3.59
The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr (2011) 2.34
Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg (2009) 2.22
Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg (2010) 1.94
The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer (2005) 1.76
Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Cancer (2007) 1.64
Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am J Clin Nutr (2011) 1.58
Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer. World J Surg (2011) 1.45
Body mass index predicts failure of surgical management in benign prostatic hyperplasia. Urol Int (2012) 1.39
A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma. Ann Surg Oncol (2011) 1.34
Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology (2006) 1.34
Systemic inflammatory response, prostate-specific antigen and survival in patients with metastatic prostate cancer. Urol Int (2006) 1.29
C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer. Ann Surg Oncol (2012) 1.29
Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer? Cancer Treat Rev (2012) 1.26
Chronic inflammation and pancreatic cancer. Best Pract Res Clin Gastroenterol (2008) 1.23
Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer. Am J Surg (2012) 1.23
A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer. Lung Cancer (2003) 1.17
Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer. Eur J Cancer (2009) 1.15
Deprivation and colorectal cancer surgery: longer-term survival inequalities are due to differential postoperative mortality between socioeconomic groups. Ann Surg Oncol (2013) 1.15
Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study. Cancer (2013) 1.14
Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host. Ann Surg (2016) 1.13
The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PLoS One (2012) 1.11
The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme. PLoS One (2013) 1.09
Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res (2013) 1.09
The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review. Future Oncol (2011) 1.09
Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer. J Thorac Oncol (2012) 1.08
Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis. Histopathology (2012) 1.07
Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy. BJU Int (2013) 1.07
A systematic review of POSSUM and its related models as predictors of post-operative mortality and morbidity in patients undergoing surgery for colorectal cancer. J Gastrointest Surg (2010) 1.07
Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer (2004) 1.05
The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer. BJU Int (2008) 1.05
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer. J Gastroenterol Hepatol (2007) 1.04
Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer. Histopathology (2012) 1.02
The clinical utility of the combination of T stage and venous invasion to predict survival in patients undergoing surgery for colorectal cancer. Ann Surg (2014) 1.01
The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer. Oncologist (2013) 0.99
The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma. Ann Surg Oncol (2012) 0.99
The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers. J Gastrointest Surg (2009) 0.99
Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications. World J Surg (2011) 0.99
Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.98
The impact of perioperative risk, tumor pathology and surgical complications on disease recurrence following potentially curative resection of colorectal cancer. Ann Surg (2011) 0.97
Elevated preoperative C-reactive protein predicts poor cancer specific survival in patients undergoing resection for non-small cell lung cancer. J Thorac Oncol (2010) 0.96
Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer. Cytokine (2004) 0.95
Circulating concentrations of "free" leptin in relation to fat mass and appetite in gastrointestinal cancer patients. Nutr Cancer (2002) 0.92
Elastica staining for venous invasion results in superior prediction of cancer-specific survival in colorectal cancer. Ann Surg (2010) 0.91
Relation between pyridoxal and pyridoxal phosphate concentrations in plasma, red cells, and white cells in patients with critical illness. Am J Clin Nutr (2008) 0.91
The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients. BMC Cancer (2013) 0.91
Enhanced Recovery After Surgery: Which Components, If Any, Impact on The Systemic Inflammatory Response Following Colorectal Surgery?: A Systematic Review. Medicine (Baltimore) (2015) 0.90
Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer. Am J Surg (2008) 0.90
The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer. Cancer Treat Rev (2012) 0.90
POSSUM and its related models as predictors of postoperative mortality and morbidity in patients undergoing surgery for gastro-oesophageal cancer: a systematic review. World J Surg (2010) 0.89
Telomere attrition and decreased fetuin-A levels indicate accelerated biological aging and are implicated in the pathogenesis of colorectal cancer. Clin Cancer Res (2011) 0.87
The impact of open versus laparoscopic resection for colon cancer on C-reactive protein concentrations as a predictor of postoperative infective complications. Ann Surg Oncol (2014) 0.86
The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphoma. Med Sci Monit (2005) 0.86
Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer. Int J Cancer (2008) 0.86
Assessment of vitamin E status in patients with systemic inflammatory response syndrome: plasma, plasma corrected for lipids or red blood cell measurements? Clin Chim Acta (2009) 0.85
Emergency presentation of node-negative colorectal cancer treated with curative surgery is associated with poorer short and longer-term survival. Int J Colorectal Dis (2014) 0.85
A comparison of POSSUM and GPS models in the prediction of post-operative outcome in patients undergoing oesophago-gastric cancer resection. Ann Surg Oncol (2011) 0.85
Postoperative C-reactive protein measurement predicts the severity of complications following surgery for colorectal cancer. Int J Colorectal Dis (2015) 0.85
The relationship between the insulin-like growth factor-1 axis, weight loss, an inflammation-based score and survival in patients with inoperable non-small cell lung cancer. Clin Nutr (2009) 0.85
Tumoral C-reactive protein and nuclear factor kappa-B expression are associated with clinical outcome in patients with prostate cancer. Cancer Biomark (2012) 0.84
The relationship between plasma and red cell concentrations of vitamins thiamine diphosphate, flavin adenine dinucleotide and pyridoxal 5-phosphate following elective knee arthroplasty. Clin Nutr (2004) 0.84
Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomy. HPB (Oxford) (2013) 0.84
Biological variation of vitamins in blood of healthy individuals. Clin Chem (2005) 0.84
Interrelationships between tumor proliferative activity, leucocyte and macrophage infiltration, systemic inflammatory response, and survival in patients selected for potentially curative resection for gastroesophageal cancer. Ann Surg Oncol (2011) 0.84
Impact of day 2 C-reactive protein on day 3 and 4 thresholds associated with infective complications following curative surgery for colorectal cancer. World J Surg (2013) 0.84
Hyperuricemia and gout in renal transplant recipients. Ren Fail (2002) 0.83
Low-serum 25-hydroxyvitamin D reflects severity of illness in critically ill patients. Crit Care Med (2012) 0.83
The relationship between the acute changes in the systemic inflammatory response, lipid soluble antioxidant vitamins and lipid peroxidation following elective knee arthroplasty. Clin Nutr (2005) 0.83
Relation between riboflavin, flavin mononucleotide and flavin adenine dinucleotide concentrations in plasma and red cells in patients with critical illness. Clin Chim Acta (2010) 0.82
Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer. BMC Cancer (2014) 0.82
Androgen receptor phosphorylation at serine 308 and serine 791 predicts enhanced survival in castrate resistant prostate cancer patients. Int J Mol Sci (2013) 0.82
Pyridoxal phosphate decreases in plasma but not erythrocytes during systemic inflammatory response. Clin Chem (2003) 0.82
Comparison of pre-treatment clinical prognostic factors in patients with gastro-oesophageal cancer and proposal of a new staging system. J Gastrointest Surg (2010) 0.81
Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer. Int J Cancer (2006) 0.81
The effect of gender on postoperative mortality after emergency abdominal surgery. Gend Med (2005) 0.80
Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer. J Gastroenterol Hepatol (2007) 0.80
Post-transplant erythrocytosis: a review of 47 renal transplant recipients. Saudi J Kidney Dis Transpl (2007) 0.79
Quantitative SERRS immunoassay for the detection of human PSA. Analyst (2009) 0.79
The relationship between plasma and red cell B-vitamin concentrations in critically-ill patients. Clin Nutr (2005) 0.79
Screening for colorectal cancer: what is the impact on the determinants of outcome? Crit Rev Oncol Hematol (2012) 0.78
Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients. Clin Sci (Lond) (2004) 0.78
Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancer. Hum Pathol (2013) 0.78
The relationship between leptin concentrations, the systemic inflammatory response and illness severity in surgical patients admitted to ITU. Clin Nutr (2004) 0.78
Systemic inflammatory response and survival in patients with localised prostate cancer: 10-year follow-up. Urol Int (2010) 0.78
Is portal hypertension associated with protein-losing enteropathy? J Gastroenterol Hepatol (2005) 0.78
Comparison of simple acid-ethanol precipitation with gel exclusion chromatography for measuring leptin binding in serum of normal subjects and cancer patients. Ann Clin Biochem (2003) 0.78
The revised ACPGBI model is a simple and accurate predictor of operative mortality after potentially curative resection of colorectal cancer. Ann Surg Oncol (2011) 0.78
Is perioperative systemic inflammation the result of insufficient cortisol production in patients with colorectal cancer? Ann Surg Oncol (2013) 0.77
The impact of surgical specialisation on survival following elective colon cancer surgery. Int J Colorectal Dis (2014) 0.77
The relationship between genetic profiling, clinicopathological factors and survival in patients undergoing surgery for node-negative colorectal cancer: 10-year follow-up. J Cancer Res Clin Oncol (2013) 0.76
Validation of a modified clinical risk score to predict cancer-specific survival for stage II colon cancer. Cancer Med (2014) 0.75
Comment on "prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases". Med Oncol (2015) 0.75
Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival. BMC Cancer (2010) 0.75
Examination of a CRP first approach for the detection of postoperative complications in patients undergoing surgery for colorectal cancer: A pragmatic study. Medicine (Baltimore) (2017) 0.75